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We read with interest a cross-sectional study conducted by
Lam et al.1 that demonstrated a significant association
between obstructive sleep apnoea (OSA) and the metabolic
syndrome in community-based Chinese adults in Hong Kong.
While this study adds to the accumulating evidence that OSA
is associated with metabolic syndrome or its components,2–5
the investigators might have overlooked a few statistical
issues of potential concern and conveyed an unsubstantiated
implication that metabolic syndrome would cause OSA.
Regression models are mathematical approximations to
reality. As the direction of causality cannot be ascertained
by a cross-sectional study design, the choice of the
dependent variable should normally tally with the best
available evidence and/or the most plausible biological
mechanism. It has been shown that treatment of OSA by
continuous positive airway pressure improves diastolic
pressure,3 insulin sensitivity,4 and total cholesterol levels.5
Thus we were surprised by the investigators’ choice of OSA
as the dependent variable in all analyses. We were also
somewhat confused by the layout of Tables 4 and 5;
metabolic syndrome and its components were listed under
dependent variable.
Besides the conceptual problem in the direction of
causality, their choice of the dependent variable might have
masked collinearity that could cause problems in fitting and
interpreting regression models. Such a concern is not without
ground; the investigators showed that OSA and body mass
index were significantly correlated (r ¼ 0.449, Po0.001).
The last statistical issue concerns their stepwise logistic
regression model. Not only may stepwise model selectionnt matter & 2006 Elsevier Ltd. All rights reserved.
2006.11.024show insufficient regard for the biological interpretation of
the model but introduce Type I error inadvertently through
multiple testing. Furthermore, stepwise selection is not too
robust; results may differ between forward and backward
stepwise selection methods.
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